Brilique, known in some countries as Brilinta, is a prescription medication primarily used to prevent cardiovascular events in individuals with acute coronary syndrome (ACS) or a history of myocardial infarction. Its active ingredient, ticagrelor, belongs to a class of drugs known as platelet aggregation inhibitors or antiplatelet agents. Brilique works by preventing platelets in the blood from clumping together to form unwanted blood clots, which can block arteries and lead to heart attacks or strokes. It is often prescribed in combination with aspirin, another antiplatelet medication, to enhance its blood-thinning effect. Due to its mechanism of action, Brilique is crucial in the management of patients at high risk of developing serious heart-related issues, helping to reduce their chances of future heart attacks or strokes.